Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

29 trials with published results (11%)

Research Maturity

180 completed trials (68% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.8%

18 terminated out of 265 trials

Success Rate

90.9%

+4.3% vs benchmark

Late-Stage Pipeline

17%

44 trials in Phase 3/4

Results Transparency

16%

29 of 180 completed with results

Key Signals

29 with results91% success18 terminated

Data Visualizations

Phase Distribution

174Total
Not Applicable (77)
Early P 1 (3)
P 1 (26)
P 2 (24)
P 3 (30)
P 4 (14)

Trial Status

Completed180
Unknown29
Recruiting20
Terminated18
Withdrawn5
Active Not Recruiting5

Trial Success Rate

90.9%

Benchmark: 86.6%

Based on 180 completed trials

Clinical Trials (265)

Showing 20 of 20 trials
NCT06935890Phase 4RecruitingPrimary

Jack Jumper Ant Venom Immunotherapy Long-term Effectiveness Investigation

NCT07832643Not ApplicableRecruitingPrimary

Primary Allergy and Its Impact on the Occurrence of Respiratory Distress in Infants at 12 Months of Age

NCT04152746Completed

Periostin Levels in Children With Adenoid Hypertrophy

NCT06762002Recruiting

Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort

NCT04215783Active Not Recruiting

Childhood Allergy and the Neonatal Environment

NCT07279467RecruitingPrimary

Study of Oral Food Challenge Biomarkers (SAFER)

NCT07611435Phase 2Recruiting

Beginning to Assess an Appropriate CONtrol for Oral Food Challenges in Alpha-Gal Syndrome (CoFAR-13) - BeACON4AG

NCT03449836Phase 3CompletedPrimary

Effects of the Direct Interaction Between Streptococcus Salivarius 24SMBc and Streptococcus Oralis 89a and the Respiratory Epithelium in Children

NCT07003919Phase 3Active Not RecruitingPrimary

Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)

NCT05476484Completed

Comparative Real World Effectiveness of SQ Sublingual Immunotherapy (SLIT)-Tablets vs. Controls in Allergic Rhinitis and Asthma

NCT04418999Early Phase 1Completed

Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus

NCT04322838Completed

Tromsø Birch Rust Allergy Study. Allergy to Birch Rust, a Possible Explanation to Seasonal Airway Allergy During Autumn?

NCT07631039Not ApplicableNot Yet RecruitingPrimary

LOGOGRAM: Validation of Allergy Care Flowcharts in Primary Care: Experience From Occitanie

NCT00798226Phase 1Active Not Recruiting

Fish Oil Supplementation During Pregnancy for Prevention of Asthma, Eczema and Allergies in Childhood

NCT02661074Completed

Anisakis Blastocystis Cryptosporidium Fish Prevalence

NCT07002814RecruitingPrimary

Direct Oral Challenges in Private Practice Setting to Delabeling Children With Beta-lactam Allergy

NCT07562009Not ApplicableNot Yet Recruiting

Investigation of Allergen Sensitization in Newborn Babies Diagnosed With Necrotizing Enterocolitis.

NCT07447869Early Phase 1RecruitingPrimary

LYmph Node eXamination in Cat Allergen Immunotherapy

NCT07103720Phase 4CompletedPrimary

The Nonirritating Concentrations of Midazolam, Ketamine, and Ondansetron

NCT01923519Not ApplicableCompletedPrimary

Study of Genic Expression Profiles of the Epithelium of the Nose and Bronchi in Healthy and Allergic Subjects

Scroll to load more

Research Network

Activity Timeline